Objective Capital

Objective Capital is a private middle-market investment banking and valuation advisory firm rather than a drug developer or healthcare operating company. The firm provides M&A advisory, valuation, capital raising, corporate development, and related financial advisory services across several sectors, including healthcare technology and life sciences services. Historical materials also show the firm operating a life sciences practice and working with biotech and healthcare clients on strategic advisory, licensing, and funding matters. Based on the available evidence, Objective Capital should be classified as a financial services company with exposure to healthcare transactions, not as a biotech, pharma, or therapeutics company.